Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Manhattan Eye, Ear & Throat Hospital Alcon Research |
---|---|
Information provided by: | Manhattan Eye, Ear & Throat Hospital |
ClinicalTrials.gov Identifier: | NCT00211419 |
The purpose of this study is to evaluate the safety of combining juxtasclerally administered anecortave acetate 15 mg with triamcinolone acetate 4 mg administered intravitreally following photodynamic therapy with verteporfin for the treatment of exudative age-related macular degeneration (AMD).
Condition | Intervention | Phase |
---|---|---|
Maculopathy, Age-Related |
Drug: Anecortave Acetate 15 mg Drug: Triamcinolone Acetate 4 mg Procedure: Photodynamic Therapy with Verteporfin Procedure: Thermal Laser |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control |
Official Title: | Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD) |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, New York | |
Manhattan Eye, Ear & Throat Hospital | |
New York, New York, United States, 10021 | |
Vitreous-Retina-Macula Consultants of NY | |
New York, New York, United States, 10022 |
Principal Investigator: | Jason S Slakter, MD | Manhattan Eye, Ear & Throat Hospital |
Study ID Numbers: | Double Injection |
Study First Received: | September 13, 2005 |
Last Updated: | February 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00211419 |
Health Authority: | United States: Food and Drug Administration |
Exudative Age-Related Macular Degeneration AMD |
Triamcinolone Acetonide Eye Diseases Triamcinolone Verteporfin Retinal Degeneration |
Macular Degeneration Triamcinolone diacetate Retinal Diseases Triamcinolone hexacetonide Retinal degeneration |
Anti-Inflammatory Agents Immunologic Factors Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Enzyme Inhibitors Glucocorticoids |
Hormones Immunosuppressive Agents Pharmacologic Actions Photosensitizing Agents Radiation-Sensitizing Agents Therapeutic Uses Dermatologic Agents |